Nasdaq Inc Stock Price, News & Analysis

Nasdaq (NDAQ) has announced a secondary public offering of 41,604,207 shares of its common stock, currently held by Argus Seller, LP, an affiliate of Thoma Bravo-managed funds. Nasdaq itself is not selling any shares and will not receive proceeds from this offering. Additionally, Nasdaq has agreed to a Concurrent Share Repurchase of 1,200,000 shares from the Selling Stockholder, capped at $120 million, as part of its existing share repurchase program to offset employee dilution.

After the offering and repurchase, the Selling Stockholder is expected to hold 42,804,207 shares, about 7.4% of Nasdaq's outstanding shares, subject to a lock-up until May 1, 2025. Goldman Sachs & Co. is the sole book-running manager for the offering. Nasdaq has filed a registration statement with the SEC for this offering.

Nasdaq, Inc. (NDAQ) has announced a quarterly dividend of $0.24 per share on its outstanding common stock. The dividend will be paid on September 27, 2024 to shareholders of record as of the close of business on September 13, 2024. This decision was made by Nasdaq's Board of Directors, who are responsible for approving future quarterly dividend declarations and establishing record and payment dates.

Nasdaq (NDAQ) reported strong Q2 2024 results with net revenues of $1.2 billion, up 25% year-over-year. Solutions revenues increased 34%, while Annualized Recurring Revenue (ARR) grew 29% to $2.7 billion. Financial Technology revenues rose 79% to $420 million, and Index revenues increased 29%. Despite GAAP diluted EPS decreasing 30%, non-GAAP diluted EPS increased 7% organically. The company returned $196 million to shareholders through dividends and share repurchases. Nasdaq's performance was driven by broad-based growth across all divisions, with double-digit Solutions growth and strong momentum in Financial Technology. The company is making progress on integration targets, AI-driven innovation, and cross-selling through its One Nasdaq strategy.

Nasdaq has released its mid-month open short interest positions for Nasdaq stocks as of July 15, 2024. Key highlights include:

- Short interest in 3,044 Nasdaq Global Market securities totaled 12,309,469,231 shares, up from 12,156,830,526 shares in 3,052 issues on June 28, 2024.

- The mid-July short interest represents 2.95 days of average daily volume, down from 3.37 days in the prior period.

- For the Nasdaq Capital Market, short interest in 1,687 securities totaled 2,046,452,681 shares, slightly up from 2,040,351,094 shares in 1,685 securities previously.

- Overall, short interest across all 4,731 Nasdaq securities totaled 14,355,921,912 shares, representing 2.56 days of average daily volume.

The Nasdaq Stock Market (NDAQ) has announced the delisting of securities from multiple companies. These include CONX Corp., Priveterra Acquisition Corp. II, Yield10 Bioscience, Aesthetic Medical International Holdings Group, Breeze Holdings Acquisition Corp., Quadro Acquisition One Corp., DermTech, TRACON Pharmaceuticals, eFFECTOR Therapeutics, Dynatronics , and Canna-Global Acquisition Corp. The delistings affect various securities such as common stocks, units, warrants, American Depositary Shares, rights, and ordinary shares.

All affected securities were suspended from trading on Nasdaq between May 6 and July 9, 2024, and have not traded since their respective suspension dates. This action is part of Nasdaq's ongoing efforts to maintain market integrity and enforce listing standards.

Nasdaq (NDAQ) has announced that Super Micro Computer Inc. (SMCI) will join the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index starting July 22, 2024. This inclusion means that Super Micro Computer Inc. will replace Walgreens Boots Alliance Inc. (WBA) in these indices. Additionally, Walgreens will be removed from the Nasdaq-100 Ex-Tech Sector™ Index, the Nasdaq-100 ESG™ Index, and the Nasdaq-100 Sustainable ESG Select™ Index on the same date. Super Micro Computer Inc. will also be considered for inclusion in various Nasdaq-100 technology sector indices during the next quarterly rebalancing.

Nasdaq has announced the end-of-month open short interest positions in Nasdaq stocks as of the settlement date, June 28, 2024. The total short interest in 3,052 Nasdaq Global Market securities reached 12,156,830,526 shares, a decrease from 12,415,199,809 shares in 3,063 issues as of June 14, 2024. This represents 3.37 days of average daily volume, down from 3.44 days in the previous period.

For the Nasdaq Capital Market, short interest in 1,685 securities totaled 2,040,351,094 shares on June 28, 2024, slightly down from 2,046,668,652 shares in 1,687 securities from the previous period, maintaining a 1.00-day average daily volume. Overall, short interest in 4,737 Nasdaq securities was 14,197,181,620 shares at the end of June, compared to 14,461,868,461 shares in 4,750 issues at the previous settlement date, averaging 2.51 days of daily volume, a decrease from 2.56 days.

Short sales typically involve selling a security the seller does not own. More details on Nasdaq short interest positions are available on Nasdaq's official websites.

Nasdaq (NDAQ) released its June 2024 monthly volumes and 2Q24 statistics, revealing key financial metrics and performance indicators. The report includes data on trading volumes, estimated revenue capture, and the number of listings for the quarter ending June 30, 2024. Detailed statistics can be accessed on their investor relations website.

Nasdaq (NDAQ) announced it welcomed 66 IPOs in the first half of 2024, raising $8.7 billion. This included 53 operating companies and 13 SPACs, reflecting a 71% win rate of Nasdaq-eligible IPOs in the U.S. market. In addition, 7 companies transferred their listings to Nasdaq, including Science Applications International Corp (SAIC) with a market cap of $7.4 billion. Notable listings included Waystar (largest U.S. company IPO), Kaspi.kz (first Kazakhstan IPO in the U.S.), and Astera Labs (largest semiconductor IPO). Nasdaq continued to lead in healthcare, technology, and biotech sectors, with 100% of eligible biotech companies listing on Nasdaq. Around 30 international companies also chose Nasdaq, contributing to nearly 50% of total IPOs. In the SPAC market, Nasdaq hosted 81% of eligible SPAC IPOs, raising $1.8 billion, and completing 35 SPAC business combinations. The IPO Pulse Index indicates continued momentum for listings in the coming months.